Below are the Nifty Weekly Expiry Options Trading Levels for Aug 04 2026 Trading What Just Happened? Decoding Today’s Nifty “CAS Fiasco” Nifty Expiry Range Upper End of Expiry : 24803 Lower End of Expiry : 24496 Nifty Intraday Trading Levels Buy Above 24670 Tgt 24720, 24773 and 24825 ( Nifty Spot Levels) Sell Below… Read More »
If you were watching your screens during market close today, you likely rubbed your eyes in disbelief. At 3:30 PM, Nifty suddenly flashed a massive print to close at 24,774, while Nifty Futures barely budged and option premiums behaved erratically. Social media blew up instantly with confusion: Was it a fat-finger trade? A ticker glitched?… Read More »
One of the biggest myths in trading is: More trades = More profits. In reality, the opposite is often true. Some of the most consistent traders I know take only 10–15 high-conviction trades in an entire month. They are not glued to charts all day. They are not chasing every breakout or every candle. They… Read More »
Fasten your seatbelts, traders. Friday’s Nifty session looked calm on the surface, eking out a quiet 94-point gain within a muted 120-point daily range. However, on the macro timeframe, a historically rare structural explosion has just taken place. By the time the closing bell rang to end July, Nifty not only broke a massive 8-month… Read More »
As the curtain closes on July, Bank Nifty is displaying one of the rarest and most explosive price compression setups a trader can witness. Friday’s session closed up by 130 points, but it was suffocated within an ultra-tight daily range of just 215 points. Beneath this calm, a “mother of all breakouts” is brewing. With Bank… Read More »
Market structure changes dictate execution strategy. The exchange has fundamentally altered the end-of-day trading mechanics for specific equities, shifting from standard continuous matching up to 3:30 PM to a structured Closing Auction Session (CAS). For active traders, understanding these micro-structural changes is critical. If you are trading CAS-eligible stocks, the traditional rules of engagement in… Read More »
It was the season’s first torrential downpour. The streets had turned into rivulets, and the relentless rain blurred the world into a hazy watercolor painting. Standing drenched in that merciless rain, outside a modest, unassuming house, was a newlywed bride clutching her dripping dupatta, her teeth chattering slightly. “Is… is this the place?” Riddhima asked, her… Read More »
Executive Summary: The Headline Strong recovery quarter: Consolidated Revenue +23% YoY to ₹4,018 Cr. PAT surged to ₹483 Cr (vs ₹47 Cr YoY — multi-fold jump). EBITDA +39% YoY to ₹805 Cr with margin expansion to 20%. Broad-based growth: India Formulations +15.5%, North America and Europe also contributed positively. Overarching narrative: Glenmark delivered a robust… Read More »
Executive Summary: The Headline Solid top-line and reported profit growth: Revenue +10.5% YoY to ₹15,300 Cr. Reported PAT +27% YoY to ₹2,895 Cr. Adjusted PAT +3.1% to ₹3,089 Cr. India and Specialty drove performance: India Formulations grew 16% YoY. Global Innovative Medicines grew 12.8%. US Formulations declined. Overarching narrative: A steady quarter for India’s largest… Read More »
Executive Summary: The Headline Exceptional profitability surge: Consolidated PAT nearly doubled (+97% YoY) to ₹4,665–4,671 Cr. Revenue +17% YoY to ₹41,350 Cr. Gas Marketing drove the beat: Natural Gas Marketing PBIT more than tripled, becoming the primary earnings engine. Transmission remained stable, while Petrochemicals stayed weak. Overarching narrative: A strong quarter for GAIL, powered by… Read More »